Drug profile · INN
testosterone
INTRINSA
- US status
- approved
- Patents linked
- 8
- News articles
- 1
Quick answer
testosterone (INTRINSA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: implantation. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12318397
Methods and compositions for testosterone production
granted -
US 12290524
Methods and compositions for testosterone production
granted -
US 11844805
Formulations of testosterone and methods of treatment therewith
granted -
US 10751348
Formulations of testosterone and methods of treatment therewith
granted -
US 10258631
Formulations of testosterone and methods of treatment therewith
granted -
US 9675653
Composition containing an essential oil product and method for using such to maintain normal levels of testosterone
granted -
US 9066904
Composition containing an essential oil product and method for using such to maintain normal levels of testosterone
granted -
US 8653057
Prophylactic perioperative testosterone supplementation for protection of and recovery of function
granted
Frequently asked questions
What is testosterone?
testosterone (INTRINSA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: implantation. Current US regulatory status: approved.
What is the brand name for testosterone?
INTRINSA is a marketed brand name for testosterone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of testosterone?
testosterone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.